Historical trends in the epidemiology of candidaemia: Analysis of an 11-year period in a tertiary care hospital in Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 3, 2013, Pages 288-292

  Wille, Marcos Paulo ^a   Guimarães, Thaís ^a   Campos Furtado, Guilherme Henrique ^a   Colombo, Arnaldo Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bloodstream infections; Candidaemia; Epidemiology

Indexed keywords

EID: 84877271389     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762013000300005     Document Type: Article

References (33)

1. Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A, Barcelona Candidemia Project Study Group 2005. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43: 1829-1835.
2. Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Moller J, Nielsen L, Rosenvinge FS, Roder B, Schonheyder HC, Thomsen MK, Truberg K 2011. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49: 325-334.
3. Arnold HM, Micek ST, Shorr AF, Zilberberg MD, Labelle AJ, Kothari S, Kollef MH 2010. Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy 30: 361-368.
4. Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F 2001. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 47: 308-313.
5. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP, National Epidemiology of Mycoses Survey (NEMIS) Study Group 2001. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The national epidemiology of mycosis survey. Clin Infect Dis 33: 177-186.
6. CLSI - Clinical and Laboratory Standards Institute 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, document M27-A2, 2nd ed, CLSI, Pennsylvania, 29 pp.
7. Colombo AL, Guimarães T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P, Alves T, Rosas RC 2007. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology and predictors of mortality. Infect Control Hosp Epidemiol 28: 570-576.
8. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44: 2816-2823.
9. Colombo AL, Nucci M, Salomão R, Branchini ML, Richtmann R, Derossi A, Wey SB 1999. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 34: 281-286.
10. Colombo AL, Thompson L, Graybill JR 2008. The north and south of candidemia: issues for Latin America. Drugs Today 44 (Suppl. A): 1-34.
11. Costa SF, Marinho I, Araújo EA, Manrique AE, Medeiros EA, Levin AS 2000. Nosocomial fungemia: a 2-year prospective study. J Hosp Infect 45: 69-72.
12. Das I, Nightingale P, Patel M, Jumaa P 2011. Epidemiology, clinical characteristics and outcome of candidemia: experience in a tertiary referral centre in the UK. Int J Infect Dis 15: e759-763.
13. França JC, Ribeiro CE, Queiroz-Telles F 2008. Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility. Rev Soc Bras Med Trop 41: 23-28.
14. Fujitani S, Ricardo-Dukelow M, Kamiya T, Sullivan L, Low L 2006. Ethnicity and other possible risk factors for candidemia at 3 tertiary care university hospitals in Hawaii. Infect Control Hosp Epidemiol 27: 1261-1263.
15. Girão E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EA, Costa SF 2008. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in intensive care units at a Brazilian university hospital. Med Mycol 46: 581-588.
16. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D 2003. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37: 1172-1177.
17. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population based active surveillance program. J Clin Microbiol 42: 1519-1527.
18. Hsueh PR, Ruan SY 2009. Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 108: 443-451.
19. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA 2003. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54: 18-24.
20. Motta AL, Almeida GM, Almeida Júnior JN, Burattini MN, Rossi F 2010. Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex. Braz J Infect Dis 14: 441-448.
21. Nucci M, Queiroz-Telles F, Tóbon AM, Restrepo A, Colombo AL 2010. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 51: 561-570.
22. Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NA, Jones BL 2007. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 56: 1066-1075.
23. Pasqualotto AC, Zimerman RA, Alves SH, Aquino VR, Branco D, Wiltgen D, do Amaral A, Cechinel R, Colares SM, da Rocha IG, Severo LC, Sukiennik TC 2008. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil. Infect Control Hosp Epidemiol 29: 898-899.
24. Pereira GH, Müller PR, Szeszs MW, Levin AS, Melhem MS 2010. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-albicans Candida species. Med Mycol 48: 839-842.
25. Pfaller MA, Diekema DJ 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
26. Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P, Syrjälä H, Ruutu P 2010. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 28: 312.
27. Sampaio Camargo TZ, Marra AR, Silva CV, Cardoso MF, Martino MD, Camargo LF, Correa L 2010. Secular trends of candidemia in a tertiary care hospital. Am J Infect Control 38: 546-551.
28. Sofair AN, Lyon GM, Huie-White S, Reiss E, Harrison LH, Sanza LT, Arthington-Skaggs BA, Fridkin SK 2006. Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin Infect Dis 43: 32-39.
29. St-Germain G, Laverdière M, Pelletier R, René P, Bourgault AM, Lemieux C, Libman M 2008. Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: report on 453 cases between 2003 and 2005. Can J Infect Dis Med Microbiol 19: 55-62.
30. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R, ECMM Working Group on Candidaemia 2004. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23: 317-322.
31. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP 1988. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645.
32. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41: 1232-1239.
33. Zilberberg MD, Shorr AF, Kollef MH 2008. Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol 29: 978-980.